Adrian Smith

Adrian Smith serves as Chief Executive Officer at Oxford Gene Technology. Oxford Gene Technology operates in the biotechnology sector with approximately 170.0 employees. Oxford Gene Technology generates annual revenue of 21000000.0.

Industry & Role Insights

• • MessageCEO tracks 381 executives in the biotechnology sector.
• • Our database includes 201,468 c suite-level executives.

Mimecast Outlook Greenhouse.io Amazon AWS Mobile Friendly Google Tag Manager AngularJS Hotjar Google Analytics reCAPTCHA Remote

microarray products fluorescence in situ hybridisation sequencing products fish probes ngs products next generation sequencing hybridization technology cytogenetics fish ngs next-generation sequencing targeted sequencing aaml solid tumors haematology genetic profiling clinical research diagnostic solutions custom ngs panels biomarker detection rare diseases genomic insights measurable residual disease mrd drug resistance mutations cancer research dna probes genetic analysis diagnostic assays research use only ivd certified probes probe design services detection assays fish assay biobank molecular genetics clinical decision support allele frequency genetic aberrations disease monitoring genetic-based medicine disease characterization patient care decisions genetic testing array-based technology custom fish probes scientific literature troubleshooting resources fish tutorials partnership opportunities research collaboration advanced diagnostics precision medicine

CB

Chip Baird Chief Executive Officer at 2seventy bio at 2seventy bio

JL

Jason Loveridge CEO at 4SC AG

MM

Marie Moores Chief Operating Officer at AB Cavalli Coach & Consultant

JR

Julie Rubinstein President and Chief Operating Officer at Adaptive Biotechnologies Corp.

CH

Chris Harano President and CEO at Advanced BioCatalytics

Outreach Guidance — biotechnology Sector

Technology executives make decisions on infrastructure, tooling, and partnerships. When reaching out to Adrian Smith, lead with your value proposition relative to the stack they currently use. Generic pitches perform poorly; specific technical relevance is key.

Adrian Smith's Position in the MessageCEO Database

• •Adrian Smith is 1 of 1 verified executive contact we track at Oxford Gene Technology.
• •365 verified executive contacts in biotechnology are in the MessageCEO database.
• •2 verified contacts work at biotechnology companies in the 170.0 employee range (same size as Oxford Gene Technology).

Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated July 2026.

How do I reach Adrian Smith directly?

Adrian Smith's verified email address is available to MessageCEO Pro subscribers. They currently serve as Chief Executive Officer at Oxford Gene Technology. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Adrian Smith work for?

Adrian Smith is Chief Executive Officer at Oxford Gene Technology, a company in the biotechnology sector with 170.0 employees.

Can I pitch or sell to Adrian Smith?

As Chief Executive Officer at Oxford Gene Technology, Adrian Smith is a key decision-maker in the biotechnology sector. MessageCEO Pro gives you verified email to reach Adrian Smith directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Adrian Smith in?

Adrian Smith works in the biotechnology industry as Chief Executive Officer at Oxford Gene Technology. MessageCEO provides verified contact information for executives across all major industries.

Is Adrian Smith's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Adrian Smith's profile is kept up-to-date with the latest available information.

Last updated: July 27, 2026